pyrazolanthrone has been researched along with 1-naphthylisothiocyanate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Dai, M; Gonzalez, FJ; Guo, B; Hua, H; Lin, H; Lin, J; Liu, A; Luo, M; Song, D; Xie, M; Xu, G; Yang, J; Zhao, J | 1 |
| Chang, L; Dai, M; Liu, A; Xu, G; Yang, J; Zheng, X | 1 |
2 other study(ies) available for pyrazolanthrone and 1-naphthylisothiocyanate
| Article | Year |
|---|---|
Inhibition of JNK signalling mediates PPARĪ±-dependent protection against intrahepatic cholestasis by fenofibrate.
Topics: 1-Naphthylisothiocyanate; Animals; Anthracenes; Cholestasis, Intrahepatic; Dose-Response Relationship, Drug; Fenofibrate; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Knockout; PPAR alpha; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Structure-Activity Relationship | 2017 |
Inhibition of inflammation by SP600125 in cholestatic liver injury is dependent on the administrationābased exposure profile.
Topics: 1-Naphthylisothiocyanate; Animals; Anthracenes; Bile Acids and Salts; Biological Transport; Biomarkers; Cholestasis; Gene Expression Regulation; Inflammation; Liver; MAP Kinase Signaling System; Mice; RNA, Messenger | 2020 |